survey released from form view

Tebon securities: bio-pharmaceutical industry-factory price survey of development and Reform Commission starts drug categories: industrial research institutions: Yantai darbond chemical industry securities limited liability company researchers: Yantai darbond chemical industry Securities Research Institute events: national development and Reform Commission raised the pharmaceutical factory price survey procedures (trial implementation) notices indicated in the notification from the 2011/12/01Implementation of the ex-factory prices of drugs investigations. National development and Reform Commission will send investigators to the price within the drug investigation. Provinces, autonomous regions and municipalities directly under the Department in charge of price level can refer to this approach organizations under Government purview of pharmaceutical factory investigation, according to the actual situation and price management needs, develop level government price departments drugs ex-factory priceThe methodology. Comments: 1. We have just in the weekly newspaper for two comments on the news last week swtor power leveling, first is the ex-factory prices of medicines and hospital use differ by huge news, the second is the national development and Reform Commission compound reserpine for two companies in Shandong monopoly investigation and handling of raw materials, let us feel is there also room for price cuts in drug prices, country squeezed dry medicine pricesWater is a must, and the other is State for improper reasons for high drug prices regulation, ensure that medicines to "normal price" "" normal supply ", especially essential medicines list of drugs.�� ����No matter what, price is the main object being control, so as always our perspective "at this stage, the price will be the pharmaceutical industry to business as usual". 2. AboutFor drug rumours of ex-factory prices last year already make a great noise, and there were even rumours of nuclear medicine cost price. Now, the State development and Reform Commission has begun the first steps. Trial measures of development and Reform Commission announced, we consider prescription drug manufacturers in particular the agency sales model manufacturer of prescription drugs swtor credits, a greater impact. Upset sale mode of medical Enterprise often ex-factory prices are low,Doing most or all of the promotion costs, their selling costs less, so the ex-factory price to the Terminal has a part to let agents, resulting in a big gap between ex-factory prices and Terminal prices.�� ����Ex-factory price of independent sales with sales charges, Terminal and ex-factory price price gap is relatively small. 3. From the files of the national development and Reform Commission, the survey select pharmaceuticals companiesIndustry representative 1-2 specifications for investigation, survey released from form view, the investigation involving the company's main business cost, expenses for the period and many other business indexes, and assembling enterprises drug patents, drug types, such as research and development ability indices, we can expect from these indicators survey of national development and Reform Commission, the ex-factory prices of medicines is a real understanding of pharmaceutical enterprisesThis, laying the foundations for future pricing, other organizations with research and development on the pricing will be italic. 4. Survey development and Reform Commission, the ex-factory price of development and Reform Commission for medicine prices strengthen understanding and the determination to control, reasonable pricing for the future laid groundwork. In addition, we believe that if you want to change drug prices down completely and a "drug" and the "To drug raising medical "this situation of formed both history causes also has hospital doctor of actual interests causes, to full changed also go; another is reduced medicine sales, circulation links, national has been advocate" two votes system ", but implementation process in the also more to has some problem, but move of implementation we think compared to" to drug raising medical "changed, implementation of difficulty will small some, also willFaster.